Influenza Vaccination Strategy for Patients With Hematologic Malignancy

Clinical trial NCT07485855 · RECRUITING

Trial details

NCT number: NCT07485855
Sponsor: Asan Medical Center
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hematologic Neoplasms Influenza Immunogenicity

Start date: 2025-12-04
Primary completion: 2027-04-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.